• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Global economic recovery slowed by vaccine inequity

, 22 September 2021/in E-News /by panglobal

Covid-19 vaccine inequity will have a lasting and profound impact on socio-economic recovery in low- and lower-middle income countries without urgent action to boost supply and assure equitable access for every country, including through dose sharing, according to new data released recently by the United Nations Development Programme (UNDP), the World Health Organization (WHO) and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/covid_vaccine-scaled.jpg 1440 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 08:29:312021-09-22 08:29:31Global economic recovery slowed by vaccine inequity

Jürgen Semmler appointed new managing director at Shimadzu Europe

, 21 September 2021/in E-News /by panglobal

Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new managing director of its European organization from July 1, 2021. Previously, head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and Kwass have both been affiliated […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Shimadzu_Jürgen-Semmler.jpg 984 904 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 13:09:102021-09-21 13:09:10Jürgen Semmler appointed new managing director at Shimadzu Europe

Medovate expands SAFIRA product range with further CE Mark approvals

, 21 September 2021/in E-News /by panglobal

Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/medovate_NRFit-scaled.jpg 1706 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 13:04:592021-09-21 13:11:36Medovate expands SAFIRA product range with further CE Mark approvals

Minaris to be commercial manufacturer in Europe for Skysona, bluebird bio’s gene therapy for CALD

, 21 September 2021/in E-News /by panglobal

Minaris Regenerative Medicine, a leading contract development and manufacturing organization for the cell and gene therapy industry, will be the commercial manufacturer in Europe for bluebird bio’s Skysona (elivaldogene autotemcel, formerly Lenti-D gene therapy), for the treatment of Early Cerebral Adrenoleukodystrophy (CALD).

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Minaris-cleanroom.jpg 1333 2000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 13:01:532021-09-21 13:01:53Minaris to be commercial manufacturer in Europe for Skysona, bluebird bio’s gene therapy for CALD

Owen Mumford receives RoSPA gold award for health and safety achievements

, 21 September 2021/in E-News /by panglobal

Owen Mumford has been awarded a RoSPA (Royal Society for the Prevention of Accidents) gold health and safety award. The awarded is given to organisations that achieve exceptional control of risk with very low levels of error, harm and loss.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/rospa.jpg 891 656 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 12:58:492021-09-21 12:58:49Owen Mumford receives RoSPA gold award for health and safety achievements

TeamViewer, Siemens Healthineers form partnership to enable new remote scanning service WeScan for diagnostic imaging

, 21 September 2021/in E-News /by panglobal

Siemens Healthineers has recently started offering its customers WeScan. WeScan is a new service that helps healthcare providers to perform magnetic resonance imaging (MRI) examinations if they lack qualified radiology staff. With the WeScan service, customers may seek access to a pool of skilled remote imaging technologists who help operate the MRI scanner using syngo […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/WeScan.png 901 1631 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 12:56:192021-09-21 12:56:19TeamViewer, Siemens Healthineers form partnership to enable new remote scanning service WeScan for diagnostic imaging

Apic Bio receives FDA Fast Track Designation for APB-102 for treatment of patients with SOD1 ALS

, 21 September 2021/in E-News /by panglobal

The US FDA has granted Fast Track designation to APB-102, Apic Bio’s lead gene therapy candidate designed to treat SOD1 amyotrophic lateral sclerosis (ALS). Apic said they plan to commence a Phase 1/2 clinical trial in early 2022.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/apic_bio.jpg 488 842 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 12:51:352021-09-21 12:52:47Apic Bio receives FDA Fast Track Designation for APB-102 for treatment of patients with SOD1 ALS

Canon Medical to reform global HIT division

, 21 September 2021/in E-News /by panglobal

Canon Medical Systems Corporation recently announced a major operational plan to strengthen its healthcare information technology (HIT) division which will see it broaden its capabilities and leverage Canon Medical’s global infrastructure to accelerate the delivery of a full range of Enterprise, AI, and collaborative imaging solutions. As part of the development, Vital Images, Inc. will […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Canon-Medical-logo.jpg 676 1772 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 12:44:282021-09-21 12:48:43Canon Medical to reform global HIT division

CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University

, 21 September 2021/in E-News /by panglobal

CN Bio, a leading organ-on-a-chip company (OOC) that designs and manufactures singleand multi-organ microphysiological systems (MPS), has secured the licensing rights to a novel tool for modelling the gut microbiome, GuMI, from Massachusetts Institute of Technology (MIT) and North-eastern University. Planned for commercial launch in 2023, the technology will be integrated into CN Bio’s PhysioMimix […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/shutterstock_1031178730-1-scaled.jpg 1707 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 12:29:482021-09-21 12:41:17CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
Dr. Satoru Komatsumoto, Emeritus Director of Ashikaga Red Cross Hospital

Join the Green Hospitals event to develop innovative practices for a sustainable future

, 13 September 2021/in E-News, Events /by panglobal
Ashikaga Red Cross Hospital

Ashikaga Red Cross Hospital, Japan’s first green hospital

 

 

Leaders of the global healthcare community are invited to attend an important virtual event looking at developing innovative practices for a sustainable future.

The event – Green Hospitals: Sharing innovative practices for a sustainable future – on  7 October (12pm – 3pm UTC), is being hosted by the International Hospital Federation and Dialog Health.

It will bring together hospital executives from around the world to share their strategies and experiences in promoting sustainability in the healthcare sector.

Climate change – a major threat to public health

Hospital and healthcare professionals are at the forefront of the fight against climate change, which is at risk of becoming the biggest public health threat of our generation:

  • If the world’s healthcare sector were a country, it would be the fifth-largest emitter of carbon emissions on the planet.
  • Medical professionals have identified climate change from carbon emissions as the ‘biggest global health threat of the 21st century’. (The Lancet, Commission on Climate Change, 2009)
  • Between 2030 and 2050, climate change is expected to cause more than 250,000 additional deaths per year.
Dr. Satoru Komatsumoto, Emeritus Director of Ashikaga Red Cross Hospital

Dr. Satoru Komatsumoto, Emeritus Director of Ashikaga Red Cross Hospital, will share his insights into designing a resilient hospital.

The keynote speaker at the event will be Dr. Satoru Komatsumoto, Emeritus Director of Ashikaga Red Cross Hospital, which is Japan’s first green hospital Dr. Komatsumoto will share his insights into designing a resilient hospital.

He commented: “Sixteen years ago, I proposed that our hospital should be eco-conscious. I wanted to create a hospital that would be beautiful and that would organically integrate all the features to meet the challenges of the future… I wondered what kind of hospital would meet the needs of our time. I studied very hard to imagine a next generation hospital.”

The program also includes speakers from Europe and the USA who will share strategies to achieve net zero carbon emissions by 2030, sustainable food circuits and building a carbon-neutral hospital. There will also be dedicated time for small group discussions with the experts to explore innovative ideas.

  • You can register here for Green Hospitals: Sharing innovative practices for a sustainable future.
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Komatsumoto_web.jpg 790 770 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-13 10:30:282021-09-13 10:30:28Join the Green Hospitals event to develop innovative practices for a sustainable future
Page 50 of 234«‹4849505152›»

Latest issue of International Hospital

April 2024

15 August 2025

International Hospital Federation announces 81 finalists across eight award categories

15 August 2025

COVID-19 vaccines prevented 2.5 million deaths worldwide, study finds

11 August 2025

Mayo Clinic unveils breakthrough tool for hidden cancer DNA analysis

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription